NASDAQ-GS · traded in Congress
Insmed INSM
$114.99 +0.585 (+0.51%) Nov 9, 2026 4:29 AM ET
Market value$25.2B
P/E ratio-
Analyst target$195.00
52-week range-
Avg volume2,914,935
Dividend yieldN/A
Chart
Analyst ratings
- 24 buy
- 1 hold
- 0 sell
Low target$158.00
Average target$194.18
High target$243.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $524M | - | $-100M | -19.1% | |
| $425M | - | $-13M | -3.1% | |
| $306M | - | $-164M | -53.5% | |
| $264M | - | $-328M | -124.5% |
Congress trades in INSM
Members of Congress disclosed 1 transaction in INSM in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 06/10/2026 | Josh Gottheimer NJ05 | Partial sale | $1,001 - $15,000 | 7/7/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
